|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cell and Developmental Biology and the Neuroscience Program, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
Calmodulin (CaM) has been shown to modulate different ion channels, including voltage-gated sodium channels (NaChs). Using the yeast two-hybrid assay, we found an interaction between CaM and the C-terminal domains of adult skeletal (NaV1.4) and cardiac (NaV1.5) muscle NaChs. Effects of CaM were studied using sodium channels transiently expressed in CHO cells. Wild type CaM (CaMWT) caused a hyperpolarizing shift in the voltage dependence of activation and inactivation for NaV1.4 and activation for NaV1.5. Intracellular application of CaM caused hyperpolarizing shifts equivalent to those seen with CaMWT coexpression with NaV1.4. Elevated Ca2+ and CaM-binding peptides caused depolarizing shifts in the inactivation curves seen with CaMWT coexpression with NaV1.4. KN93, a CaM-kinase II inhibitor, had no effect on NaV1.4, suggesting that CaM acts directly on NaV1.4 and not through activation of CaM-kinase II. Coexpression of hemi-mutant CaMs showed that an intact N-terminal lobe of CaM is required for effects of CaM upon NaV1.4. Mutations in the sodium channel IQ domain disrupted the effects of CaM on NaV1.4: the I1727E mutation completely blocked all calmodulin effects, while the L1736R mutation disrupted the effects of Ca2+calmodulin on inactivation. Chimeric channels of NaV1.4 and NaV1.5 also indicated that the C-terminal domain is largely responsible for CaM effects on inactivation. CaM had little effect on NaV1.4 expressed in HEK cells, possibly due to large differences in the endogenous expression of ß-subunits between CHO and HEK cells. These results in heterologous cells suggest that Ca2+ released during muscle contraction rapidly modulates NaCh availability via CaM.
(Received 15 December 2004;
accepted after revision 28 February 2005;
first published online 3 March 2005)
Corresponding author J. H. Caldwell: Campus Box 8315, Dept. of Cell/Devel Biology, UCHSC, PO Box 6511, Aurora, CO 80045, USA. Email: john.caldwell{at}uchsc.edu
This article has been cited by other articles:
![]() |
V. A. Maltsev, V. Reznikov, N. A. Undrovinas, H. N. Sabbah, and A. Undrovinas Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1597 - H1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Biswas, I. Deschenes, D. DiSilvestre, Y. Tian, V. L. Halperin, and G. F. Tomaselli Calmodulin Regulation of NaV1.4 Current: Role of Binding to the Carboxyl Terminus J. Gen. Physiol., February 25, 2008; 131(3): 197 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Pitt Calmodulin and CaMKII as molecular switches for cardiac ion channels Cardiovasc Res, March 1, 2007; 73(4): 641 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Choi, A. Hudmon, S. G. Waxman, and S. D. Dib-Hajj Calmodulin Regulates Current Density and Frequency-Dependent Inhibition of Sodium Channel Nav1.8 in DRG Neurons J Neurophysiol, July 1, 2006; 96(1): 97 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaneko, F. Mohrlen, and S. Frings Calmodulin Contributes to Gating Control in Olfactory Calcium-activated Chloride Channels J. Gen. Physiol., May 30, 2006; 127(6): 737 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fucile, A. Sucapane, F. Grassi, F. Eusebi, and A. G. Engel The human adult subtype ACh receptor channel has high Ca2+ permeability and predisposes to endplate Ca2+ overloading J. Physiol., May 15, 2006; 573(1): 35 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Camacho, S. Hensellek, J.-S. Rougier, S. Blechschmidt, H. Abriel, K. Benndorf, and T. Zimmer Modulation of Nav1.5 Channel Function by an Alternatively Spliced Sequence in the DII/DIII Linker Region J. Biol. Chem., April 7, 2006; 281(14): 9498 - 9506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rezazadeh, T. W. Claydon, and D. Fedida KN-93 (2-[N-(2-Hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor, Is a Direct Extracellular Blocker of Voltage-Gated Potassium Channels J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 292 - 299. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |